Scott Langille

Scott Langille

No open positions remaining
69 year
Health Technology
Consumer Services
Utilities

Profile

Scott M.
Langille
worked as Director-Corporate Finance at Biovail Corp.
Served as CFO, Director & Head-Investor Relations at Aralez Pharmaceuticals Canada, Inc. from 2011 to 2016.
Held the position of Finance Director at AltiMed Pharmaceuticals Co. and Biovail Pharmaceuticals Canada.
Worked as Chief Financial Officer at Sparta Capital Ltd., Sernova Biotherapeutics, Inc. from 2016 to 2018, Wayland Group Corp., ViRexx Medical Corp.
from 2006 to 2007, Cipher Pharmaceuticals, Inc. from 2020 to 2022, and Pure Global Cannabis, Inc. in 2020.
Held the role of Vice President at Biovail Pharmaceuticals LLC and Controller at Zimmer of Canada Ltd. Education includes undergraduate studies at Toronto Metropolitan University and an MBA from the University of Toronto.

Former positions of Scott Langille

CompaniesPositionEnd
CIPHER PHARMACEUTICALS INC. Director of Finance/CFO 15/08/2022
PURE GLOBAL CANNABIS INC. Director of Finance/CFO 01/05/2020
SERNOVA BIOTHERAPEUTICS INC Director of Finance/CFO 04/05/2018
TRIBUTE PHARMACEUTICALS CANADA INC Director of Finance/CFO 01/01/2016
Director of Finance/CFO 01/05/2007
See the detail of Scott Langille's experience

Training of Scott Langille

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

7

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Utilities

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

AltiMed Pharmaceuticals Co.

Zimmer of Canada Ltd.

Distribution Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Scott Langille